OXALIPLATIN WOCKHARDT oxaliplatin 100mg/20 mL concentrate for solution for infusion vial

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

oxaliplatin, Quantity: 100 mg

から入手可能:

Wockhardt Bio Pty Ltd

INN（国際名）:

Oxaliplatin

医薬品形態:

Injection, concentrated

構図:

Excipient Ingredients: nitrogen; water for injections

投与経路:

Intravenous Infusion

パッケージ内のユニット:

1 vial

処方タイプ:

(S4) Prescription Only Medicine

適応症:

Oxaliplatin is indicated for adjuvant treatment of stage III (Duke?s C) colon cancer, in combination with fluoropyrimidine agent.,Oxaliplatin in combination with fluorouracil and folinic acid is indicated for the treatment of advanced colorectal cancer.,Oxaliplatin in combination with capecitabine, with or without bevacizumab, is indicated for the treatment of patients with metastatic colorectal cancer,Oxaliplatin in combination with epirubicin and either capecitabine or fluorouracil, is indicated for the treatment of patients with advanced oesophagogastric cancer.

製品概要:

Visual Identification: Clear, colorless solution containing 5 mg/ml Oxaliplatin.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store below 25 degrees Celsius

認証ステータス:

Licence status A

承認日:

2017-10-13

情報リーフレット

1
OXALIPLATIN WOCKHARDT
OXALIPLATIN WOCKHARDT
(
_Oxaliplatin_
)
CONSUMER MEDICINE INFORMATION
other staff will take all of the
aware of
WHAT IS IN THIS LEAFLET
precautions needed to reduce the
•
you are taking any other
unwanted effects of treatment.
This leaflet answers some common
medicines, including medicines
that you have bought without a
questions about Oxaliplatin injection. It
does
not
contain
all
the
available
information.
Oxaliplatin Wockhardt is only
available on a prescription from your
doctor.
prescription from a pharmacy,
supermarket or health food shop.
Your doctor or pharmacist can tell you
It does not take the place of talking to
your doctor or pharmacist.
All medicines have benefits and risks.
Your doctor has weighed the risks of
using
Oxaliplatin
Wockhardt
against
the benefits it is expected to have for
you.
IF
YOU
HAVE
ANY
CONCERNS
ABOUT
TAKING THIS MEDICINE, ASK YOUR DOCTOR
OR PHARMACIST.
WHAT OXALIPLATIN
WOCKHARDT IS USED FOR
Oxaliplatin Wockhardt is used to treat
cancer
of
the
oesophagus/stomach,
large intestine and rectum (colorectal
cancer).
Oxaliplatin Wockhardt is used in
combination with other anti-cancer
drugs;
capecitabine,
bevacizumab,
epirubicin, fluorouracil (FU), and/or
folinic acid. The active ingredient in
Oxaliplatin Wockhardt is called
oxaliplatin.
Cancer
cells
are
normal
cells
which
have changed so that they grow in an
uncontrolled way. Oxaliplatin works
by interfering with cancer cell growth.
BEFORE YOU ARE GIVEN
OXALIPLATIN WOCKHARDT
_WHEN YOU MUST NOT RECEIVE IT _
_ _
YOU SHOULD NOT BE GIVEN OXALIPLATIN
WOCKHARDT IF YOU ARE ALLERGIC TO THE
ACTIVE INGREDIENT 'OXALIPLATIN'.
If you have had an allergic reaction to
oxaliplatin before, you should not
receive it again.
YOU MUST NOT RECEIVE OXALIPLATIN
WOCKHARDT IF YOU ARE PREGNANT OR
BREASTFEEDING.
Oxaliplatin may cause birth defects if
you are being treated with it at the time
of conception or it is given to women
who are already pregnant.
Adequate contraception is required
during treatment with oxaliplatin.
You should discu

製品の特徴

OXALIPLATIN WOCKHARDT V2.3
Version 2.3
Page 1 of 38
AUSTRALIAN PRODUCT INFORMATION – OXALIPLATIN WOCKHARDT
(OXILAPLATIN) CONCENTRATED INJECTION FOR INTRAVENOUS INFUSION
1
NAME OF THE MEDICINE
Oxilaplatin
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
OXALIPLATIN WOCKHARDT is available as a concentrated solution for
infusion in
50mg/10mL and 100mg/20mL vials
Oxaliplatin is a white to off-white crystalline powder. It is slightly
soluble in water, very
slightly soluble in methanol and practically insoluble in ethanol.
For the full list of excipients, see
SECTION 6.1 LIST OF EXCIPIENTS
.
3
PHARMACEUTICAL FORM
Concentrated injection for intravenous infusion in a clear glass vial
4
CLINICAL PARTICULARS
4.1
T
HERAPEUTIC INDICATIONS
Oxaliplatin is indicated for adjuvant treatment of stage III (Duke’s
C) colon cancer, in
combination with fluoropyrimidine agent.
Oxaliplatin in combination with fluorouracil and folinic acid is
indicated for the treatment of
advanced colorectal cancer.
Oxaliplatin in combination with capecitabine, with or without
bevacizumab, is indicated for
the treatment of patients with metastatic colorectal cancer.
Oxaliplatin in combination with epirubicin and either capecitabine or
fluorouracil, is indicated
for the treatment of patients with advanced oesophagogastric cancer.
4.2
D
OSE AND METHOD OF ADMINISTRATION
DOSAGE
In combination with fluorouracil and folinic acid for adjuvant
treatment of colon cancer, the
recommended dose of oxaliplatin is 85 mg/m
2
intravenously repeated every two weeks for 12
cycles (6 months).
In combination with capecitabine for adjuvant treatment of colon
cancer, the recommended
dose of oxaliplatin is 130 mg/m
2
, administered as an intravenous infusion over 2 hours on day
OXALIPLATIN WOCKHARDT V2.3
Version 2.3
Page 2 of 38
1 of a three week cycle. For the recommended doses of capecitabine
(see Section 5.1
PHARMACODYNAMIC PROPERTIES
).
In combination with fluorouracil and folinic acid for the treatment of
advanced colorectal
cancer, the recommended dose of oxaliplatin is 8